Think your odds of R&D success are miserable? MIT’s Andrew Lo might have a surprise for you
Maybe the odds of success in a clinical trial aren’t as miserable as just about everyone in the biopharma R&D sector assumes.
MIT professor Andrew …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
